0 Cell Therapeutics Analyst Ratings, Earnings, Dividends and Insider Trades | $CTICD | NASDAQ:CTICD | Analyst Ratings Network

Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cell Therapeutics Company Profile (NASDAQ:CTICD)

Consensus Ratings for Cell Therapeutics (NASDAQ:CTICD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $6.00 (Infinity upside)

Analysts' Ratings History for Cell Therapeutics (NASDAQ:CTICD)
DateFirmActionRatingPrice TargetDetailsShare
1/2/2014Roth CapitalBoost Price Target$4.50 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/18/2012 forward)